Cadila Healthcare Ltd., a research-oriented pharmaceutical company in India belonging to Zydus group, said it has inked a new drug discovery and development pact with Eli Lilly and Co. focused in the area of cardiovascular research.
134679
Cadila Healthcare inks drug discovery pact with Eli Lilly
117484
Medicis to acquire LipoSonix
143153
Cardiac medical device shows promise in clinical trial
123926
A new prescription to crush a pill mill problem
79421
Medfusion acquires Medem's iHealth services
90632
Scientists discover potential drug delivery system
94913
Dell acquisition helps healthcare push
58492
Sun Pharma has target of Rs 540:
120060
IGMH to be handed to a Singapore company
79889
Merck buys drug rival Schering-Plough
175864
Bristol-Myers Squibb establishes strategic partnership with PAREXEL to enable greater effectiveness
115795
Researchers identify new drug target for heart failure
34605
Eli Lilly acquires SGX Pharmaceuticals
19743
Boston Scientific assigned patent for drug delivery
145835
Novocell announces non-exclusive drug discovery collaboration with Pfizer
6492
Eisai launches epilepsy drug in UK
88639
ICON selected as Pfizer strategic partner